Glenmark schedules Q2 FY2027 earnings call for November 6, 2026

Board & Shareholder Meetings View source PDF Explain this filing

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹2166.60

prior close

₹2135.60

announcement price

After-mkt

timing

Nifty Midcap 150market+1.1%+1.7% vs market

Pharmaceuticals peers, median of 174sector+1.2%+1.5% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Midcap 150 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.5

15m

+1.3

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.7+1.1+1.7+1.2+1.5

Next day

+4.6+2.0+2.6+3.1+1.5

+6.2pendingpending+4.7+1.5

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Glenmark will discuss its unaudited results for the quarter ended September 30, 2026, during an earnings call on November 6, 2026, from 8:30 am to 9:30 am IST. The filing gives dial-in details but no financial figures.

Likely market impact

The filing has no performance figures. The call may lead to stock price volatility as investors assess the results and management outlook.